Stock MNKA MANUKA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Manuka, Inc.

Equities

MNKA

US04302Q1094

Delayed OTC Markets
Other stock markets
 20:22:11 26/06/2024 BST 		5-day change 1st Jan Change
0.03 USD 0.00% Intraday chart for Manuka, Inc. 0.00% -58.33%
2023 Manuka, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Manuka, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Manuka, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Manuka Announces Review of Strategic Alternatives
GL
Manuka, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Manuka, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
ARTEMIS THERAPEUTICS, INC. - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
AQ
ARTEMIS THERAPEUTICS, INC. - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
AQ
ARTEMIS THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
AQ
Artemis Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Artemis Therapeutics Inc. Auditor Raises 'Going Concern' Doubt
CI
ARTEMIS THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Artemis Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
ARTEMIS THERAPEUTICS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
ARTEMIS THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Artemis Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
ARTEMIS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
ARTEMIS THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
Artemis Therapeutics Inc. Announces Executive Changes
CI
Artemis Therapeutics : Opinion on the Financial Statements - Form 8-K
PU
ARTEMIS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Results of Operations and Financial Condition, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Change in Shell Company Status, Financial Statements and Exhibits (form 8-K)
AQ
Manuka Ltd completed the acquisition of Artemis Therapeutics Inc. in a reverse merger transaction.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MNKA Stock
  4. News Manuka, Inc.